Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC, 71000-71001 [2019-27784]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
71000
Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices
period of Presidential review. See 19
U.S.C. 1337(j)(3).
The private parties petitioned for the
Commission to review certain of the
ALJ’s determinations. On December 4,
2018, after considering the parties’
petitions and responses thereto, the
Commission determined to review the
following issues:
(1) Whether 10X indirectly infringes
the ’682 and ’635 patents;
(2) Whether 10X’s Chip GB infringes
claims 1 and 14 of the ’664 patent; and
(3) Whether 10X’s Chip SE infringes
claim 20 of the ’160 patent and claim 1
of the ’664 patent.
83 FR 63672 (Dec. 11, 2018). The
Commission thereafter requested
briefing only on remedy, the public
interest, and bonding.
On June 10, 2019, the Commission
requested supplemental briefing on the
public interest. 84 FR 27802 (June 14,
2019); 84 FR 31912 (July 3, 2019)
(modifying briefing schedule).
Thereafter, the parties, members of the
public, and a government agency
submitted public interest briefing.
On review, and consistent with the
simultaneously-issued Commission
opinion, the Commission has
determined to affirm with modification
the final ID’s finding of a violation of
section 337 with respect to claims 1, 2,
14, and 15 of the ’664 patent, claims 14,
16, and 17 of the ’682 patent, and claims
1, 13, 14, 16, and 21 of the ’635 patent.
The Commission has further
determined that the public interest
factors enumerated in subsections (d)(l)
and (f)(1) (19 U.S.C. 1337(d)(l), (f)(1)) do
not preclude issuance of the abovereferenced remedial orders. However,
the Commission has determined to
tailor the LEO and CDO to allow
research studies using the infringing
articles at issue as of the date of
issuance of the remedial orders to
continue to use those infringing articles.
The Commission has determined to
impose a bond of three (3) percent of
entered value of the covered products
during the period of Presidential review
(19 U.S.C. 1337(j)).
This investigation is terminated.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and in part 210 of the Commission’s
Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: December 18, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–27759 Filed 12–23–19; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
16:53 Dec 23, 2019
Jkt 250001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–562]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturers of Marihuana: Stanley
Brothers Bio Tec Inc.
ACTION:
Notice of application.
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic classes of
controlled substances listed in schedule
I. Prior to making decisions on this and
other pending applications, DEA
intends to promulgate regulations that
govern the program of growing
marihuana for scientific and medical
research under DEA registration.
DATES: Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 24, 2020.
SUMMARY:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–562 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
classes, and applicants therefore, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If its application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a Bulk
Manufacturer of Marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a) as described
in 84 FR 44920, published on August
27, 2019.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on October 31, 2019, STANLEY
BROTHERS BIO TECH INC., 66 South
Logan Street, Suite 209, Denver,
Colorado 80209–1809 applied to be
registered as a bulk manufacturer of the
following basic class of controlled
substances:
Controlled
substance
Drug code
Marihuana ...............
Tetrahydrocannabinols.
7360
7370
Schedule
I
I
ADDRESSES:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
The applicant noticed above applied
to become registered with DEA to grow
marihuana as a bulk manufacturer
subsequent to a 2016 DEA policy
statement that provided information on
how it intended to expand the number
of registrations, and described in general
terms the way it would oversee those
additional growers. Before DEA
completes the evaluation and
registration process for applicants to
grow marihuana, DEA intends to
propose regulations in the near future
that would supersede the 2016 policy
statement and govern persons seeking to
become registered with DEA to grow
marihuana as bulk manufacturers,
consistent with applicable law, as
described in 84 FR 44920.
Dated: December 6, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–27782 Filed 12–23–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–561]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem
LLC
ACTION:
E:\FR\FM\26DEN1.SGM
Notice of application.
26DEN1
71001
Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 24, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on October 25, 2019,
Kinetochem LLC, 111 W Cooperative
Way, Suite 310–B, Georgetown, Texas
78626 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
Controlled
substance
Drug code
Marihuana ...............
Tetrahydrocannabinols.
7360
7370
Schedule
I
I
The company plans to synthetically
manufacture drug codes 7360
(marihuana) and 7370
(tetrahydrocannabinols), in bulk for
distribution and sale to its customers.
No other activities for these drug codes
are authorized for this registration.
Dated: December 6, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–27784 Filed 12–23–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–559]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturers of Marihuana: Royal
Emerald Pharmaceuticals Research
and Development
ACTION:
Notice of application.
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic classes of
controlled substances listed in schedule
I. Prior to making decisions on this and
other pending applications, DEA
intends to promulgate regulations that
govern the program of growing
marihuana for scientific and medical
research under DEA registration.
DATES: Registered bulk manufacturers of
the affected basic classes, and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:53 Dec 23, 2019
Jkt 250001
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 24, 2020.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–559 in all correspondence,
including attachments.
ADDRESSES:
The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
classes, and applicants therefore, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If its application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a Bulk
Manufacturer of Marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a) as described
in 84 FR 44920, published on August
27, 2019.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on September 24, 2019, Royal Emerald
Pharmaceuticals Research and
Development, 7220 Trade Street, Suite
340, San Diego, California 92121–2324
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Controlled
substance
Drug code
Marihuana Extract
Marihuana .............
Tetrahydrocannabinols ....................
Schedule
7350
7360
1
I
7370
I
The applicant noticed above applied
to become registered with DEA to grow
marihuana as a bulk manufacturer
subsequent to a 2016 DEA policy
statement that provided information on
how it intended to expand the number
of registrations, and described in general
terms the way it would oversee those
additional growers. Before DEA
completes the evaluation and
registration process for applicants to
grow marihuana, DEA intends to
propose regulations in the near future
that would supersede the 2016 policy
statement and govern persons seeking to
become registered with DEA to grow
marihuana as bulk manufacturers,
consistent with applicable law, as
described in 84 FR 44920.
Dated: December 6, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–27783 Filed 12–23–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–563]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturers of Marihuana:
Agronomed Pharmaceuticals
ACTION:
Notice of application.
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic classes of
controlled substances listed in schedule
I. Prior to making decisions on this and
other pending applications, DEA
intends to promulgate regulations that
govern the program of growing
marihuana for scientific and medical
research under DEA registration.
DATES: Registered bulk manufacturers of
the affected basic classes, and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 24, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
SUMMARY:
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 84, Number 247 (Thursday, December 26, 2019)]
[Notices]
[Pages 71000-71001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27784]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-561]
Bulk Manufacturer of Controlled Substances Application:
Kinetochem LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
[[Page 71001]]
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 24, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on October 25, 2019, Kinetochem LLC, 111 W Cooperative
Way, Suite 310-B, Georgetown, Texas 78626 applied to be registered as a
bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana............................ 7360 I
Tetrahydrocannabinols................ 7370 I
------------------------------------------------------------------------
The company plans to synthetically manufacture drug codes 7360
(marihuana) and 7370 (tetrahydrocannabinols), in bulk for distribution
and sale to its customers. No other activities for these drug codes are
authorized for this registration.
Dated: December 6, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-27784 Filed 12-23-19; 8:45 am]
BILLING CODE 4410-09-P
